What if you couldn't perform daily activities, such as exercising or running with your children, because of overly large breasts that caused unending pain? Despite existing scientific studies that outline the medical necessity for breast reduction, many insurance companies are denying thousands of women the procedure each year because of rigid, unfounded conditions to secure coverage, according to a study presented today at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2006 conference in San Francisco.
"People often think breast reduction is an elective cosmetic procedure, but the majority of women seeking this surgery are legitimately debilitated by their breasts," said Michael Wheatley, MD, ASPS Member Surgeon and paper co-author. "The criteria most insurance companies use is not supported by medical literature and eliminates a large number of women from coverage, forcing them to fend for themselves."
Most insurance companies require patients to exhibit specific signs and symptoms prior to approving breast reduction as medically necessary. The amount of tissue removed to relieve symptoms associated with overly large breasts is the most controversial of all insurance criteria.
The authors reviewed the breast reduction policies of 87 health insurance companies. Despite contrary medical studies, 85 companies require a minimum amount of tissue to be removed to cover the procedure – 49 of these companies require a minimum amount to be removed independent of the patient's height and weight.
According to published studies, although most patients have a one-and-a-half to two cup size reduction, the amount of tissue removed, body weight, level of obesity, or bra cup size do not affect the benefits that patients receive from breast reduction.
Many insurance companies require that patients exhibit all of the following symptoms to receive coverage for breast reduction: back, neck, shoulder, and arm pain; rashes; bra strap grooves; and numbness in the upper torso. The authors found that while most patients suffer from many of these symptoms, rarely do they exhibit all.
According to Dr. Wheatley, most patients are women between 30 and 50 years old who have had upper skeletal pain for years. Many of them have tried various treatments, including physical therapy and pain medications, to manage the pain before turning to breast reduction. However, many of these women are still turned away by their insurance companies.
According to ASPS statistics, more than 114,000 breast reductions were performed in 2005.
LaSandra Cooper | EurekAlert!
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology